| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for VITR from our risk checks.
Vitrolife AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr157.60 |
| 52 Week High | kr244.20 |
| 52 Week Low | kr123.90 |
| Beta | 1.58 |
| 1 Month Change | -20.48% |
| 3 Month Change | -9.79% |
| 1 Year Change | -30.82% |
| 3 Year Change | -50.47% |
| 5 Year Change | -21.28% |
| Change since IPO | 2,119.72% |
Recent News & Updates
Vitrolife (STO:VITR) Is Carrying A Fair Bit Of Debt
Apr 03
A Look At The Fair Value Of Vitrolife AB (publ) (STO:VITR)
Mar 07Recent updates
Vitrolife (STO:VITR) Is Carrying A Fair Bit Of Debt
Apr 03A Look At The Fair Value Of Vitrolife AB (publ) (STO:VITR)
Mar 07Vitrolife AB (publ) Just Missed Earnings; Here's What Analysts Are Forecasting Now
Feb 05Vitrolife AB (publ)'s (STO:VITR) Share Price Matching Investor Opinion
Jan 05Here's Why We Think Vitrolife (STO:VITR) Is Well Worth Watching
Dec 15Calculating The Intrinsic Value Of Vitrolife AB (publ) (STO:VITR)
Nov 27Is Vitrolife (STO:VITR) A Risky Investment?
Nov 06An Intrinsic Calculation For Vitrolife AB (publ) (STO:VITR) Suggests It's 27% Undervalued
Aug 25Vitrolife (STO:VITR) Could Easily Take On More Debt
Aug 03Are Vitrolife AB (publ) (STO:VITR) Investors Paying Above The Intrinsic Value?
May 26Is Vitrolife (STO:VITR) A Risky Investment?
Jan 23Vitrolife (STO:VITR) Seems To Use Debt Quite Sensibly
Oct 18Calculating The Fair Value Of Vitrolife AB (publ) (STO:VITR)
Sep 09Is Vitrolife (STO:VITR) A Risky Investment?
Jul 07A Look At The Fair Value Of Vitrolife AB (publ) (STO:VITR)
May 26Vitrolife (STO:VITR) Seems To Use Debt Rather Sparingly
Mar 31Estimating The Fair Value Of Vitrolife AB (publ) (STO:VITR)
Feb 07There May Be Reason For Hope In Vitrolife's (STO:VITR) Disappointing Earnings
Apr 29Is Vitrolife AB (publ)'s (STO:VITR) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Mar 16Who Has Been Selling Vitrolife AB (publ) (STO:VITR) Shares?
Jan 22Vitrolife (STO:VITR) Shareholders Have Enjoyed An Impressive 289% Share Price Gain
Dec 18
Shareholder Returns
| VITR | SE Biotechs | SE Market | |
|---|---|---|---|
| 7D | -6.2% | 2.5% | -0.7% |
| 1Y | -30.8% | -3.4% | 4.4% |
Return vs Industry: VITR underperformed the Swedish Biotechs industry which returned -5.3% over the past year.
Return vs Market: VITR underperformed the Swedish Market which returned 10.3% over the past year.
Price Volatility
| VITR volatility | |
|---|---|
| VITR Average Weekly Movement | 5.4% |
| Biotechs Industry Average Movement | 9.5% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in SE Market | 13.1% |
| 10% least volatile stocks in SE Market | 3.5% |
Stable Share Price: VITR's share price has been volatile over the past 3 months.
Volatility Over Time: VITR's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 1,132 | Bronwyn Brophy O´Connor | www.vitrolife.com |
Vitrolife AB (publ) provides assisted reproduction products. It also offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. In addition, the company offers EmbryoScope and time-lapse systems; time-lapse dishes; and evaluation tools for time-lapse systems.
Vitrolife AB (publ) Fundamentals Summary
| VITR fundamental statistics | |
|---|---|
| Market cap | kr21.34b |
| Earnings (TTM) | -kr3.84b |
| Revenue (TTM) | kr3.50b |
6.1x
P/S Ratio-5.6x
P/E RatioIs VITR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VITR income statement (TTM) | |
|---|---|
| Revenue | kr3.50b |
| Cost of Revenue | kr1.53b |
| Gross Profit | kr1.97b |
| Other Expenses | kr5.81b |
| Earnings | -kr3.84b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Jul 17, 2024
| Earnings per share (EPS) | -28.33 |
| Gross Margin | 56.39% |
| Net Profit Margin | -109.63% |
| Debt/Equity Ratio | 14.9% |
How did VITR perform over the long term?
See historical performance and comparisonDividends
0.6%
Current Dividend Yield-4%
Payout RatioDoes VITR pay a reliable dividends?
See VITR dividend history and benchmarks| Vitrolife dividend dates | |
|---|---|
| Ex Dividend Date | Apr 26 2024 |
| Dividend Pay Date | May 03 2024 |
| Days until Ex dividend | 0 days |
| Days until Dividend pay date | 7 days |
Does VITR pay a reliable dividends?
See VITR dividend history and benchmarks